Investtechs modellporteføljer steg i andre kvartal gjennomsnittlig 1.3 prosentpoeng i forhold til referanseindeks.
Spesielt porteføljene i Tyskland og Finland viste gode resultater, med meravkastning på henholdsvis 5.3 og 9.9 prosentpoeng.
Marked | Meravk. Q1* | Meravk. Q2* | Meravk. Q3* | Meravk. Q4* | Meravk. 2012 |
Stockholm | +8.6% | -6.2% | +2.4% | ||
Helsinki | +2.0% | +9.9% | +11.9% | ||
Amsterdam | +5.3% | -1.4% | +3.9% | ||
København | +4.2% | +4.2% | +8.4% | ||
Oslo | +5.3% | -4.1% | +1.2% | ||
Frankfurt/CDAX | +1.1% | +5.3% | +6.4% | ||
Snitt | +4.4% | +1.3% | +5.7% | ||
Oslo Traderporteføljen | +47.3% | -25.5% | +21.8% | ||
Stockholm Traderporteføljen | +16.9% | -4.4% | +12.5% | ||
Oslo Hold-deg-unna-portefølje | -5.4% | +5.8% | +0.4% |
I hele perioden er det lagt vekt på at aksjene i modellporteføljene skulle gjenspeile markedssammensetningen, og risikoen i porteføljene har vært på linje med markedet. Dette tatt i betraktning anses de samlede resultatene gode. Traderporteføljene søker aktivt høy risiko/oppside og har ingen krav til sektormiks.
Strategien fra tidligere anses fortsatt god:
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.